{"entity":{"id":"nct06867705","kind":"trial","name":"Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only","aka":[],"tldr":"A phase 3 trial of Resilience PRO in advanced solid tumours, run by Resilience, now recruiting.","summary":"Randomized Controlled Trial of Remote Symptoms Monitoring With Resilience PRO Compared to Care As Usual Only is a phase 3 interventional study registered as NCT06867705 by Resilience, with 1458 participants planned, started 2025-04-01 and due to reach its primary completion in 2027-01. Interventions recorded: Resilience PRO.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT06867705","url":"https://clinicaltrials.gov/study/NCT06867705"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT06867705","phase":"3","setting":"Digital Monitoring With Patient-Reported Outcomes in Cancer Care: A Randomized Controlled Trial RC - 102 (Resilience Care - 102)","sponsor":"Resilience","enrolled":1458,"outcomes":[]},"route":"/trials/nct06867705/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}